Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways
Cardiovascular Research · 30.04.2024 · 120 (5) · 476-489
DOI: 10.1093/cvr/cvad183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 18.12.2023. Verfasst von Srividya Velagapudi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Chemistry, University of Zurich and University Hospital of Zurich, Rämistrasse 100, CH-8091 Zürich, Switzerland. Hauptthemen laut MEDLINE: Atherosclerosis, Endothelial Cells, Lipoproteins, HDL, Lipoproteins, LDL. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, European Commission, Systems X Program.
Abstract (Originalsprache)
Aims
The entry of lipoproteins from blood into the arterial wall is a rate-limiting step in atherosclerosis. It is controversial whether this happens by filtration or regulated transendothelial transport. Because sphingosine-1-phosphate (S1P) preserves the endothelial barrier, we investigated in vivo and in vitro, whether S1P and its cognate S1P-receptor 3 (S1P3) regulate the transendothelial transport of lipoproteins. Methods and results Compared to apoE-haploinsufficient mice (CTRL), apoE-haploinsufficient mice with additional endothelium-specific knock-in of S1P3 (S1P3-iECKI) showed decreased transport of LDL and Evan’s Blue but increased transport of HDL from blood into the peritoneal cave. After 30 weeks of high-fat diet feeding, S1P3-iECKI mice had lower levels of non-HDL-cholesterol and less atherosclerosis than CTRL mice. In vitro stimulation with an S1P3 agonist increased the transport of 125I-HDL but decreased the transport of 125I-LDL through human aortic endothelial cells (HAECs). Conversely, inhibition or knock-down of S1P3 decreased the transport of 125I-HDL but increased the transport of 125I-LDL. Silencing of SCARB1 encoding scavenger receptor B1 (SR-BI) abrogated the stimulation of 125I-HDL transport by the S1P3 agonist. The transendothelial transport of 125I-LDL was decreased by silencing of SCARB1 or ACVLR1 encoding activin-like kinase 1 but not by interference with LDLR. None of the three knock-downs prevented the stimulatory effect of S1P3 inhibition on transendothelial 125I-LDL transport.
Conclusion
S1P3 regulates the transendothelial transport of HDL and LDL oppositely by SR-BI-dependent and SR-BI-independent mechanisms, respectively. This divergence supports a contention that lipoproteins pass the endothelial barrier by specifically regulated mechanisms rather than passive filtration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Chemistry, University of Zurich and University Hospital of Zurich, Rämistrasse 100, CH-8091 Zürich, Switzerland.
- Department of Medicine and Surgery-Unit of Neurosciences, University of Parma, Parma, Italy.
- Department of Biomedical, Metabolic and Neural Sciences-Unit of Endocrinology, University of Modena and Reggio Emilia, Modena, Italy.
- Central Laboratory Facility, University Hospital of Münster, Münster, Germany.
- Institute of Laboratory Medicine, Marien-Hospital Osnabrück, Niels-Stensen-Kliniken, Osnabrück, Germany.
ORCID-Profile: Dongdong Wang, Francesco Poti, Grigorios Panteloglou, Manuela Simoni, Arnold von Eckardstein
Förderung
- Swiss National Science Foundation
- European Commission
- Systems X Program
- Deutsche Forschungsgemeinschaft
- Center for Laboratory Medicine
- Italian Ministry of Education
- Young Investigators
- Italian Ministry of Health
Zitieren
APA
Velagapudi, S., Wang, D., Poti, F., Feuerborn, R., Robert, J., Schlumpf, E., Yalcinkaya, M., Panteloglou, G., Potapenko, A., Simoni, M., Rohrer, L., Nofer, J. R., & von Eckardstein, A. (2024). Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways. Cardiovascular Research, 120(5), 476-489. https://doi.org/10.1093/cvr/cvad183
Vancouver
Velagapudi S, Wang D, Poti F, Feuerborn R, Robert J, Schlumpf E, et al. Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways. Cardiovascular Research. 2024;120(5):476-489. doi:10.1093/cvr/cvad183
BibTeX
@article{Velagapudi2024,
author = {Velagapudi, Srividya and Wang, Dongdong and Poti, Francesco and Feuerborn, Renata and Robert, Jerome and Schlumpf, Eveline and Yalcinkaya, Mustafa and Panteloglou, Grigorios and Potapenko, Anton and Simoni, Manuela and Rohrer, Lucia and Nofer, Jerzy-Roch and von Eckardstein, Arnold},
title = {Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways},
journal = {Cardiovascular Research},
year = {2024},
volume = {120},
number = {5},
pages = {476--489},
doi = {10.1093/cvr/cvad183}
}
EUVIMED